
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/14/2025 | Q1 | -- | $3.1M | $0.06 | -- | -- |
12/31/2024 | Q4 | -- | $3.8M | $0.07 | -- | -- |
11/12/2024 | Q3 | -- | $8.4M | $0.17 | -- | -- |
08/08/2024 | Q2 | -- | $8.8M | $0.18 | -- | -- |
05/09/2024 | Q1 | -- | $6M | $0.12 | -- | -- |
12/31/2023 | Q4 | -- | $14.4M | $0.31 | -- | -- |
11/08/2023 | Q3 | -- | -- | $0.07 | -- | -- |
08/09/2023 | Q2 | -- | -- | $0.12 | -- | -- |
05/10/2023 | Q1 | -- | -- | $0.10 | -- | -- |
12/31/2022 | Q4 | -- | -- | $0.33 | -- | -- |
11/14/2022 | Q3 | -- | -- | $0.58 | -- | -- |
08/15/2022 | Q2 | -- | -- | $0.16 | -- | -- |
05/16/2022 | Q1 | -- | -- | $0.08 | -- | -- |
12/31/2021 | Q4 | -- | -- | $0.07 | -- | -- |
11/15/2021 | Q3 | -- | -- | $0.06 | -- | -- |
08/16/2021 | Q2 | -- | -- | $0.06 | -- | -- |
05/17/2021 | Q1 | -- | -- | $0.04 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.04 | -- | -- |
11/09/2020 | Q3 | -- | -- | $0.03 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.04 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.13 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.11 | -- | -- |
11/12/2019 | Q3 | -- | -- | $0.13 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.09 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.09 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.16 | -- | -- |
11/05/2018 | Q3 | -- | -- | $0.15 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.15 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.20 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.16 | -- | -- |
11/07/2017 | Q3 | -- | -- | $0.13 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.15 | -- | -- |
05/09/2017 | Q1 | -- | -- | $0.20 | -- | -- |
03/21/2017 | Q4 | -- | -- | $0.16 | -- | -- |
11/09/2016 | Q3 | -- | -- | $0.13 | -- | -- |
08/04/2016 | Q2 | -- | -- | $0.08 | -- | -- |
07/04/2016 | Q1 | -- | -- | $0.05 | -- | -- |
04/04/2016 | Q4 | -- | -- | $0.06 | -- | -- |
11/30/2015 | Q3 | -- | -- | $0.12 | -- | -- |
Permian Basin Royalty Trust reported $3.1M worth of top line sales in its most recent quarter.
Permian Basin Royalty Trust announced earnings per share of $0.06 which represents a beat of analyst forecast a -- per share.
Permian Basin Royalty Trust reported -- that represents -- per share over the last quarter.
Permian Basin Royalty Trust's earnings are forecast to grow from $0.55 per share to -- per share next year representing an increase of --.
Permian Basin Royalty Trust's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.